Apogee Therapeutics (APGE) Retained Earnings (2022 - 2026)
Apogee Therapeutics (APGE) reported Retained Earnings of -$749000.0 for Q1 2026, down 169.74% year-over-year from $1.1 million in Q1 2025, and down 169.35% quarter-over-quarter from $1.1 million in Q4 2025.
Apogee Therapeutics (APGE) Retained Earnings (2022 - 2026) Analysis & Trends
Apogee Therapeutics (APGE) has 5 years of Retained Earnings data on file, last reported at -$749000.0 in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$749000.0, down 169.74% year-over-year; the trailing twelve-month figure through Mar 2026 was -$749000.0 (down 169.74% YoY), and the FY2025 annual result was $1.1 million, up 18.03% from the prior year.
- Retained Earnings fell to -$749000.0 in Q1 2026 per APGE's latest filing, from $1.1 million in the prior quarter.
- Over five years, Retained Earnings peaked at $1.1 million in Q4 2025 and troughed at -$492.4 million in Q3 2025.
- A 5-year average of -$131.1 million and a median of -$71.2 million in 2023 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2024 and 2026: Retained Earnings jumped 178.12% in 2024, then plunged 169.74% in 2026.
- A 5-year view of Retained Earnings shows it stood at -$39.8 million in 2022, then surged by 100.83% to $329000.0 in 2023, then jumped by 178.12% to $915000.0 in 2024, then gained by 18.03% to $1.1 million in 2025, then tumbled by 169.35% to -$749000.0 in 2026.
- Business Quant data shows APGE's Retained Earnings at -$749000.0 in Q1 2026, $1.1 million in Q4 2025, and -$492.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Apogee Therapeutics | 6.29 Bn | 5.23 Bn | - | -749,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -749,000.00 |
| Dec 31, 2025 | 1.08 Mn |
| Sep 30, 2025 | -492.40 Mn |
| Jun 30, 2025 | -427.40 Mn |
| Mar 31, 2025 | 1.07 Mn |
| Dec 31, 2024 | 915,000.00 |
| Sep 30, 2024 | -238.70 Mn |
| Jun 30, 2024 | -189.70 Mn |
| Mar 31, 2024 | -155.86 Mn |
| Dec 31, 2023 | 329,000.00 |
| Sep 30, 2023 | -92.04 Mn |
| Jun 30, 2023 | -71.20 Mn |
| Dec 31, 2022 | -39.79 Mn |